BioVaxys Technology (BioVaxys Technology) Other Long Term Assets : $0.13 Mil (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Other Long Term Assets?

BioVaxys Technology's other long-term assets for the quarter that ended in Jul. 2023 was $0.13 Mil.

BioVaxys Technology's quarterly other long-term assets increased from Jan. 2023 ($0.11 Mil) to Apr. 2023 ($0.13 Mil) and increased from Apr. 2023 ($0.13 Mil) to Jul. 2023 ($0.13 Mil).

BioVaxys Technology's annual other long-term assets increased from Oct. 2020 ($0.00 Mil) to Oct. 2021 ($0.19 Mil) but then declined from Oct. 2021 ($0.19 Mil) to Oct. 2022 ($0.11 Mil).

BioVaxys Technology Other Long Term Assets Historical Data

The historical data trend for BioVaxys Technology's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Other Long Term Assets Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Other Long Term Assets

0.19

0.11

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Other Long Term Assets	Get a 7-Day Free Trial															0.17	0.11	0.11	0.13	0.13

BioVaxys Technology Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.